Trust Bio-sonics

Trust Bio-sonics is a pharmaceutical company focused on drug developments, specializing in the developments of the microbubble and ultrasound-responsive formulations for early diagnosis and treatment of cancers. Our philosophy is to achieve early diagnosis and early treatment through our advanced technologies and provide entirely new treatment options for hard-to-cure diseases. Our product portfolio includes conventional and targeted ultrasound contrast agents, molecular ultrasound imaging solution, and ultrasound drug delivery system, among other areas. Our most leading product has entered multi-country Phase III clinical trials

Ultrasound contrast agent (microbubble),ceus,contrast-enhanced ultrasound,ultrasound molecular imaging,ultrasound drug delivery,drug delivery technologies,and drug delivery

Trust bio-sonics operates in the Biotechnology research industry.

Trust bio-sonics's revenue is 11m - 100m

Trust bio-sonics has 11 - 50 employees.